“Direct cost of potentially inappropriate prescription, according to STOPP/START criteria in geriatric patients with diabetes type 2 hospitalized in a third level institution” (2020) Ciencia y Salud Virtual, 12(2), pp. 63–76. doi:10.22519/21455333.1526.